Somatuline
Drug
Ipsen Innovation
Total Payments
$12,137
Transactions
9
Doctors
5
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $12,137 | 9 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,125 | 4 | 83.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,200 | 1 | 9.9% |
| Travel and Lodging | $496.86 | 3 | 4.1% |
| Food and Beverage | $315.25 | 1 | 2.6% |
Top Doctors Receiving Payments for Somatuline
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Medical Oncology | Houston, TX | $4,270 | 3 |
| Giuseppe Giaccone | Specialist | Bethesda, MD | $3,703 | 2 |
| , MD | Medical Oncology | Tampa, FL | $1,575 | 1 |
| , M.D., PH.D | Hematology & Oncology | New York, NY | $1,389 | 2 |
| , MD, MS | Hematology & Oncology | New York, NY | $1,200 | 1 |
Ad
Manufacturing Companies
- Ipsen Innovation $12,137
Product Information
- Type Drug
- Total Payments $12,137
- Total Doctors 5
- Transactions 9
About Somatuline
Somatuline is a drug associated with $12,137 in payments to 5 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is Ipsen Innovation.
Payment data is available from 2018 to 2018. In 2018, $12,137 was paid across 9 transactions to 5 doctors.
The most common payment nature for Somatuline is "Consulting Fee" ($10,125, 83.4% of total).